A detailed history of Accordant Advisory Group Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Accordant Advisory Group Inc holds 563 shares of MRK stock, worth $57,352. This represents 0.05% of its overall portfolio holdings.

Number of Shares
563
Previous 563 -0.0%
Holding current value
$57,352
Previous $69.7 Million 8.27%
% of portfolio
0.05%
Previous 0.07%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 18, 2024

SELL
$123.8 - $132.96 $776,226 - $833,659
-6,270 Reduced 91.76%
563 $69.7 Million
Q1 2024

Apr 22, 2024

BUY
$113.24 - $131.95 $773,768 - $901,614
6,833 New
6,833 $902 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $258B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Accordant Advisory Group Inc Portfolio

Follow Accordant Advisory Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Accordant Advisory Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Accordant Advisory Group Inc with notifications on news.